Home
Rishi Delan Pathirana's picture

Rishi Delan Pathirana

Researcher
  • E-mailRishi.D.Pathirana@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2020). Responsiveness to influenza vaccination correlates with nkg2c-expression on nk cells. Vaccines. 1-18.
  • Show author(s) (2020). Live-attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction. Journal of Infectious Diseases. 21-32.
  • Show author(s) (2016). Live attenuated influenza vaccine in children induces b-cell responses in tonsils. Journal of Infectious Diseases. 722-731.
  • Show author(s) (2016). Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies. Vaccine. 3576-3583.
  • Show author(s) (2015). Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains. Human Vaccines & Immunotherapeutics. 1654-1662.
  • Show author(s) (2015). Matrix M H5N1 vaccine induces cross-H5 clade humoral immune responses in a randomized clinical trial and provides protection from highly pathogenic influenza challenge in ferrets. PLOS ONE.
  • Show author(s) (2015). Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. Journal of Infectious Diseases. 1541-1549.
  • Show author(s) (2015). Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. Human Vaccines & Immunotherapeutics. 1235-1243.
  • Show author(s) (2014). Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. Vaccine. 4550-4557.
  • Show author(s) (2013). A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. Influenza and Other Respiratory Viruses. 1181-1193.
  • Show author(s) (2012). The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine. Influenza and Other Respiratory Viruses. 90-100.
  • Show author(s) (2012). T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. Journal of Infectious Diseases. 158-166.
  • Show author(s) (2012). A(H1N1)pdm09 Vaccination of Health Care Workers: Improved Immune Responses in Low Responders Following Revaccination. Journal of Infectious Diseases. 1660-1669.
Reader opinion piece
  • Show author(s) (2013). A(H1N1)pdm09 Vaccination of Healthcare Workers: Improved Immune Responses in Low Responders Following Revaccination Reply. Journal of Infectious Diseases. 1186-1188.

More information in national current research information system (CRIStin)